Ziwig Endotest®
Diagnosis of Endometriosis
ApprovedActive
Key Facts
About Ziwig
Ziwig is a Paris-based, private diagnostics company pioneering a novel AI-powered platform that analyzes salivary RNA to detect diseases, starting with endometriosis. Its first product, Ziwig Endotest®, is a CE-marked in vitro diagnostic device that uses a saliva sample and next-generation sequencing to identify miRNA biomarkers, offering a reliable, non-invasive alternative to surgical diagnosis. The company operates an integrated ecosystem from R&D at the Paris Brain Institute to its own high-throughput lab, Ziwig Lab, positioning itself to expand its platform into other female pathologies and potentially beyond.
View full company profileTherapeutic Areas
Other Diagnosis of Endometriosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Non-invasive Endometriosis Diagnostic Test | Endometrics | Pre-clinical/Validation |